Tech-assisted self-selection concurred with clinician-assessed eligibility in >90% of cases
OMT may be right for some with Graves’ eye disease
Surprise findings argue for caution about testosterone use in men at risk for fracture
Perserverance may depend on several specifics, including medication type, insurance coverage and medium-term weight loss
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Newly identified pathway may explain the so-called niacin paradox
It's time to increase testing for this major cardiovascular risk factor in advance of new therapies
Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease
Undetectable levels achieved for nearly nine months in phase 1 trial
Study sheds light on how clinicians addressed their patients’ pain and insomnia during the pandemic
For now, antibody testing is recommended only when considering an alternative diagnosis